STOCK TITAN

Kestra Medical Technologies to Participate in Upcoming Investor Conferences

Kestra Medical Technologies (KMTS) is scheduled to participate in the Wolfe Research Healthcare Conference on November 10, 2026.

(Neutral)

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

Tags
conferences

Kestra Medical Technologies (KMTS) is scheduled to participate in the Wolfe Research Healthcare Conference on November 10, 2026.

Its presentation is at 2:40 p.m. ET. Kestra will also present at the Stifel Healthcare Conference on November 11 at 2:00 p.m. ET and Piper Sandler’s 38th Annual Healthcare Conference on December 1 at 11:00 a.m. ET. Live webcasts and replays will be available on Kestra’s investor relations website.

Loading...
Loading translation...

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google

KIRKLAND, Wash., Oct. 30, 2026 (GLOBE NEWSWIRE) -- Kestra Medical Technologies, Ltd. (Nasdaq: KMTS), a leading wearable medical device and digital healthcare company, is scheduled to participate in the following upcoming investor conferences:

Event: Wolfe Research Healthcare Conference 2026
Date: Tuesday, November 10
Presentation time: 2:40 p.m. ET

Event: Stifel Healthcare Conference 2026
Date: Wednesday, November 11
Presentation time: 2:00 p.m. ET

Event: Piper Sandler 38th Annual Healthcare Conference
Date: Tuesday, December 1
Presentation time: 11:00 a.m. ET

Interested parties may access the live webcast and replay of each presentation by visiting the Kestra investor relations website.

About Kestra
Kestra Medical Technologies, Ltd. is a leading wearable medical device and digital healthcare company focused on transforming patient outcomes in cardiovascular disease using monitoring and therapeutic intervention technologies that are intuitive, intelligent, and connected. For more information, visit www.kestramedical.com.



Investor contact
Neil Bhalodkar
neil.bhalodkar@kestramedical.com

Keep reading